Prostate cancer (PCa) is the sixth most common type of cancer globally and the most prevalent in men, accounting for about 10% of all cancer cases. In the world population, about 3% of men die from PCa. The worldwide average estimated five-year survival rate is 58%. Incidence rates are about six times higher in developed countries compared to developing countries.
PCa is considered a cancer of the elderly, because about three quarters of the cases throughout the world occur at 65 years of age or older. The authors here have assess whether the Intensity Modulated Radiotherapy (IMRT) should be considered as the most appropriate method of external radiation therapy for the treatment of patients with prostate cancer. Is there a difference in the efficacy of treatment of prostate tumors with IMRT? It is evident that surgery, radiotherapy and brachytherapy are effective approaches for disease…
